Precision BioSciences (DTIL) Misses Q4 EPS by 6c

Precision BioSciences (NASDAQ: DTIL) reported Q4 EPS of ($0.26), $0.06 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $10.59 million versus the consensus estimate of $6.81 million.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.

You May Also Be Interested In

• Pelagos Insurance Capital (PLGO) PT Raised to $28 at Citizens on Rising Book Value
• Bernstein SocGen Group Upgrades AENA SME SA (AENA:SM) (ANNSF) to Outperform
• Kepler Cheuvreux Upgrades Maire Tecnimont (MT:IM) to Buy